蜜芽传媒

New research in England has shown that cervical cancer rates are 87% lower in women who were offered vaccination against human papillomavirus (HPV) when they were between the ages of 12-13 than in previous generations. This is the first direct evidence of prevention of cervical cancer using the vaccine, Cervarix. More than a-hundred countries now use the human papillomavirus vaccine. Ninety percent of cervical cancer deaths occur in poorer countries, where there's little screening.

Kate Sanger is the head of policy and communications at Jo's Cervical Cancer Trust, a UK based cervical cancer charity:

鈥淚t鈥檚 incredibly positive to see really solid evidence of the success of the HPV Vaccine in reducing cervical cancer cases and that鈥檚 going to lead to lives saved in the future. In the UK it鈥檚 been offered since 2008. That means that girls who were offered it first are now about 25, 26 and are coming into the cervical screening programme for the first time.鈥�

鈥淭he optimal age [to receive the vaccine] is around 11 or 12 years old and that鈥檚 when the school-based programme vaccinates both girls - and boys now - because it鈥檚 most likely there won鈥檛 have been exposed to the HPV, that鈥檚 when the body is most receptive to the vaccine and make it as effective as possible.鈥�

(Pic: Teenage girl is vaccinated against diseases caused by the human papillomavirus (HPV) such as cervical cancer; Credit: Science Photo Library)

Show less